IMU 1.85% 5.3¢ imugene limited

Good to see we getting Finance News coverage...

  1. 3,333 Posts.
    lightbulb Created with Sketch. 436
    Good to see we getting Finance News coverage

    http://www.finnewsnetwork.com.au/CompanyReports/Imugene-Limited/Imugene-Announces-PD|||1-Cancer-Vaccine-Development-Update

    Imugene Announces PD-1 Cancer Vaccine Development Update

    23 Jul 2018 10:13 AM
    • New PD-1 cancer vaccine named KEY-Vaxx

    • Phase 1 planning well advanced

    • Preclinical results in validated models of colorectal (colon) cancer
    demonstrate inhibitory cancer growth activity

    MELBOURNE Australia 23 July 2018: Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company is pleased to announce a development update of its newly acquired PD-1 cancer vaccine from Ohio State University. The check-point inhibitor cancer vaccine named KEY-Vaxx, demonstrates superior cancer growth inhibition compared with an industry-standard monoclonal antibody in validated models of colorectal (colon) cancer (CT26).
    Last edited by Graphite101: 23/07/18
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.3¢
Change
-0.001(1.85%)
Mkt cap ! $389.5M
Open High Low Value Volume
5.5¢ 5.6¢ 5.3¢ $615.0K 11.39M

Buyers (Bids)

No. Vol. Price($)
25 2977440 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 283236 4
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.